The Mesothelioma Applied Research Foundation is the only national nonprofit dedicated to eradicating the life-ending effects of #mesothelioma. #curemeso
Washington, DC
Joined June 2009
- Tweets3.9K
- Following762
- Followers2.3K
- Likes866
Come work at the #Mesothelioma Applied Research Foundation and make a difference on behalf of patients, caregivers, and those who have lost a loved one to mesothelioma! #curemeso
curemeso.org/2024/03/22/come…
Make sure you follow the Meso Foundation at its new home: threads.net/@mesofoundation
#Mesothelioma Researchers: Watch this video for strategies for applying for $3 million in research funding by the Congressionally Directed Medical Research Program. Mesothelioma is one of 20 topics eligible for $130 million in appropriation funding. youtu.be/Gd8tZQzGqiY
On Monday, May 1, at 1:30 PM ET, join us as we participate in this @CancerCare #mesothelioma workshop. Guests include @RTaylorRipley, MD; Hedy Kindler, MD; Julie Powers, Executive Director, @curemeso. cancercare.org/connect_works…
The Meso Foundation has grown!
Meet our new team members and learn more about them by clicking the link below. curemeso.org/2023/04/12/welc…
Funding opportunity from the NCI: #mesothelioma research funding in the amount of $300,000!
sbir.cancer.gov/small-busine…
Mesothelioma Applied Research Foundation retweeted
@Latinamd highlights the disparities in outcomes of pts with #meso treated with surgery. Access to centers with high volume is so critical for this complex procedure and rare disease @curemeso
Disparities in Survival Due to Social Determinants of Health & Access to Treatment in US Patients With Operable #MalignantPleuralMesothelioma #HealthDisparities @JAMANetworkOpen
@SylvesterCancer @Alnajar_MD @SamuelKareffMD jamanetwork.com/journals/jam…
Mesothelioma Applied Research Foundation retweeted
Important work, despite new standards of care evolving in mesothelioma, disparities are persistent. White pts make up almost 90% of pts with operable meso however the relatively small number of black pts have the worst outcome. @curemeso – at Baltimore, MD
Disparities in Survival Due to Social Determinants of Health & Access to Treatment in US Patients With Operable #MalignantPleuralMesothelioma #HealthDisparities @JAMANetworkOpen
@SylvesterCancer @Alnajar_MD @SamuelKareffMD jamanetwork.com/journals/jam…
Yesterday, we were joined by Marjorie Zauderer, MD of
@MSKCancerCenter and Aaron Mansfield, MD (@AMansfieldMD) of @MayoClinic to discuss immunotherapy for #mesothelioma. Thank you both for a great session! youtu.be/zy7tdt2GWQA
Mesothelioma Applied Research Foundation retweeted
Colleagues, please consider activating this trial at your sties for patients with sarcomatoid mesothelioma with potentially resectable disease. @curemeso
New Trial! .@AMansfieldMD @MayoClinic leads @ALLIANCE_org A082101 to evaluate the safety & effectiveness of giving immunotherapy before surgery for controlling disease in pts w/stage I-IIIa #sarcomatoid #mesothelioma. Learn more, visit bit.ly/Alliance-A082101 #NCI #NCTN
DoD #mesothelioma research funding pre-announcement released to allow investigators time to plan and develop ideas for submission to the anticipated FY23 funding opportunities. Includes new $3 million funding mechanism. cdmrp.health.mil/pubs/press/…
Today is #RareDiseaseDay!
With approximately 3,000 Americans diagnosed every year, #mesothelioma is considered a rare disease. But rare shouldn't mean INVISIBLE! Help us show the impact of this cancer by sharing this post. To learn more, visit curemeso.org.
On Thursday, January 26 at 2:30 PM ET, join us as we participate in the US Food and Drug Administration (FDA) Patient Listening Session on mesothelioma.
The session will feature:
• An overview of mesothelioma;
• Diagnosis, care, and survivorship;
• FDA's role in treatment approvals with a discussion about the most recent immunotherapy indication;
• Personal accounts of several patients.
The session can be accessed via Zoom & viewers can ask questions through the Zoom chat box.
If you're in our database as a patient, caregiver, or bereaved person, you have received call-in information by email. If you didn't receive it, please contact [email protected].
CALLING #MESOTHELIOMA RESEARCHERS: Please take a few moments to complete.
curemeso.org/2023/01/06/requ…
What constitutes a mesothelioma diagnosis?
Watch the answer and much more in this video with Dr. Andrea Wolf of Mount Sinai in NYC. youtu.be/hX-wbRSA3fY
Mesothelioma Applied Research Foundation retweeted
Congrats @BMBurtMD @BCM_Surgery @BCMHouston_News @BCMCancerCenter @bcmhouston @BCMFromtheLabs @BCM_Thoracic @curemeso #mesothelioma for publication of Pre-Operative Immune Checkpoint Inhibitors.
bcm.edu/news/preoperative-im…
A recent review of cases of pericardial mesothelioma at one institution by @michael_offin indicated improved survival for patients who underwent multi-modality treatment (surgery, chemotherapy, radiation) at a center with multi-disciplinary expertise. curemeso.org/2022/12/08/ultr…
Don't miss the new season of MesoTV! The first four episodes are out, featuring information about new clinical trials, mesothelioma programs across country, pleural and peritoneal surgery, and much more! curemeso.org/get-involved/me…
